TickerGuard
Buy Day today: Poor (42) Weak market breadth · today: Nonfarm Payrolls (October)
HURA

TuHURA Biosciences Inc

Healthcare · Biotechnology

1.60$ -6.4% vs. previous close Closing price · As of: Nov 5, 2026

Ownership

Ownership Structure

Who owns TuHURA Biosciences Inc (HURA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 62.3% of the shares are freely tradable; institutional investors hold 15.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 15.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 34.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 62.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 12.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 64Mio.

Largest Shareholders

Institutions

Institutions HURA
Name Stake (%) Shares Change (%) Date
Vanguard Capital Management, LLC 3.56 2,267,901 +9.3 06/30/2026
Northern Trust Corp 2.54 1,621,042 +443.6 06/30/2026
BlackRock Inc 1.08 690,088 -71.8 06/30/2026
Geode Capital Management, LLC 0.76 484,219 -50.9 06/30/2026
Millennium Management LLC 0.71 454,535 +0.0 06/30/2026
AQR Capital Management LLC 0.67 424,600 -30.1 06/30/2026
Vanguard Fiduciary Trust Co 0.39 251,186 -12.5 06/30/2026
Citadel Advisors Llc 0.36 232,319 +0.0 06/30/2026

Funds

Funds HURA
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.73 1,740,756 +0.0 09/30/2026
Fidelity Extended Market Index 0.33 212,985 +2.8 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?